[1] Françoise V, Zhi W, Commere P, et al.USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression[J]. Sci Rep, 2019, 9(1):4066.
[2] Dzimianski JV, Scholte F, Bergeron É, et al.ISG15: it's complicated[J]. J Mol Biol, 2019, 431(21):4203-4216.
[3] Juncker M, Kim C, Reed R, et al.ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells[J]. Mol Basis Dis, 2021,1867(6):166102.
[4] Xin BT, Jin G, Fernandez DJ, et al.Total chemical synthesis of murine ISG15 and an activity-based probe with physiological binding properties[J]. Org Biomol Chem, 2019, 17(48): 10148-10152.
[5] Jiang Y, Wang X.Structural insights into the species preference of the influenza B virus NS1 protein in ISG15 binding[J]. Protein Cell, 2019, 10(9): 681-687
[6] Freitas BT, Scholte F, Bergeron R, et al.How ISG15 combats viral infection[J]. Virus Res, 2020, 9(286): 198036.
[7] Burks J, Fleury A, Livingston S, et al.ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression[J]. Cancer Immunol Immun,2019, 68(12): 2029-2039.
[8] Sandy Z, Costa I, Schmidt CK.More than meets the ISG15: Emerging roles in the DNA damage response and beyond[J]. Biomolecules, 2020, 10(11):1557.
[9] Swaim CD, Canadeo LA, Huibregtse JM .Approaches for investigating the extracellular signaling function of ISG15 - ScienceDirect[J]. Methods Enzymol, 2019, 618(1): 211-227.
[10] Liu H, Shi B, Zhang Z, et al.PRRSV vaccine strain-induced secretion of extracellular ISG15 stimulates porcine alveolar macrophage antiviral response against PRRSV[J]. Viruses, 2020, 12(9): 1009.
[11] Xin BT, Jin G, Fernandez DJ, et al.Total chemical synthesis of murine ISG15 and an activity-based probe with physiological binding properties[J]. Org Biomol Chem, 2019,17(48):10148-10152.
[12] Fernández DJ, Hess S, Knobeloch KP.Strategies to target ISG15 and USP18 toward therapeutic applications[J]. Front Chem, 2020, 21(7): 923.
[13] Pacella I, Spinelli F R, Severa M, et al.ISG15 protects human Tregs from interferon alpha nduced contraction in a cell‐intrinsic fashion[J]. Clin Transl Immunology, 2020, 9(12):1221.
[14] Held T, Basler M, Knobeloch K, et al.Evidence for an involvement of the ubiquitin‐like modifier ISG15 in MHC class I antigen presentation[J]. Eur J Immunol, 2021,51(1):138-150
[15] Lius S, Karaganiss S, Mo RF, et al.IFNβ treatment inhibits nerve injury-induced mechanical allodynia and MAPK signaling by activating ISG15 in mouse spinal cord.[J]. J Pain,2020;21(7-8):836-847.
[16] Buda G, Valdez RM, Biagioli G, et al.Inflammatory cutaneous lesions and pulmonary manifestations in a new patient with autosomal recessive ISG15 deficiency case report[J]. Allergy Asthma Clin Immunol,2020,16(1):77.
[17] Swaim CD, Canadeo LA, Monte KJ, et al.Modulation of extracellular ISG15 signaling by pathogens and viral effector proteins[J]. Cell Rep,2020,31(11):107772.
[18] Desai SD, Wood LM, Tsai YC, et al.ISG15 as a novel tumor biomarker for drug sensitivity[J]. Mol Cancer Ther, 2008,7(6):1430.
[19] Zhou S, Ren M, Xu H, et al.Inhibition of ISG15 enhances the anti-cancer effect of trametinib in colon cancer cells[J]. Onco Targets Ther,2019,26(12):10239-10250.
[20] Yi H, Zong Z, Wang Q, et al.ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair[J]. Oncotarget,2017,8(64):107452-107461.
[21] Chen RH, Xiao ZW, Yan X Q, et al.Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype[J]. Front Immunol, 2020,23(11):594775.
[22] Chen RH, Yong D, Ping H, et al.ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma[J]. Oncotarget, 2016,7(13):16910-16922.
[23] Kong EB, Kim HD, Kim J.Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15[J]. Cell Death Differ, 2020,27(8):2517-2530.
[24] Alcalá S, Sancho P, Martinelli P, et al.ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity[J]. Nat Commun,2020,11(1):2682.
[25] Sun J, Yan J, Qiao H Y, et al.Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation[J]. Oncogene.2020,39(3):546-559.
[26] Sainz B, Martin B, Tatari M, et al.ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells[J]. Cancer Res, 2014,74(24):7309-20.
[27] Bektas N, Noetzel E, Veeck J, et al.The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer[J]. Breast Cancer Res, 2008, 10(4): R58.
[28] Desai SD, Reed RE, Burks J, et al.ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells[J]. Adv Exp Med Biol,2012,237(1):38-49.
[29] Tecalco-Cruz A, Cortes-Gonzalez CC, Cruz-Rams Z, et al.Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells[J]. Cell Signal, 2019,2(54):91-101.
[30] Forys J, Kuzmicki C, Saporita A, et al.ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis[J]. Cell Rep, 2014 ,7(2):514-526.
[31] Wood L M, Pan ZK, Seavey MM, et al.The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy[J]. Cancer Immunol Immun, 2012,61(5):689-700.
[32] Burks J, Reed RE, Desai SD.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective[J]. Oncotarget, 2015,6(9):7221-7231.
